MYCN and skin basal cell carcinoma: Noticeably, the Hippo-YAP pathway and N-Myc target genes are significantly upregulated in BCC [67], as well as IL17 pathway targets, including cytokines such as CXCL9 and matrix metalloproteinases involved in tumoral inflammation, such as MMP1 and MMP10 [78].